SmartPatch study for adults on dialysis with an arm access
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how well a wearable patch (“SmartPatch”) can be used safely and correctly in adults who are receiving long-term dialysis through an arm fistula or graft. It may help researchers improve how medical devices are used in people with end-stage kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be on regular (maintenance) dialysis for end-stage kidney disease using an arm fistula or arm graft for at least 6 months.
- You must be able to follow the study instructions and wear the SmartPatch as directed.
- You must be able to give written consent to join the study.
- The skin near where the patch will go must not be swollen, infected, or very inflamed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a treatment (called AMSCs) to help stop scar-like narrowing at the connection point of a new arm dialysis fistula. If it works and is safe, it could improve long-term fistula function so dialysis can work better.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This study tests whether a special ultrasound implant (EchoMark) helps a new dialysis fistula mature properly. It involves people with advanced kidney disease who are starting or already on dialysis and are having a fistula created in the upper arm.
This study follows people with kidney failure who need dialysis access, when they receive an AV (artery-to-vein) access graft made from a processed donor artery. It’s meant to track safety and how well the new graft performs in real-world care.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
This study tests a device that uses light to check the health of your AV access (the blood vessel connection used for dialysis) without touching it. It may help doctors spot problems early.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.